316 related articles for article (PubMed ID: 7750187)
1. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
Lemay A; Dodin S; Cédrin I; T-Lemay L
Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
[TBL] [Abstract][Full Text] [Related]
2. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
[TBL] [Abstract][Full Text] [Related]
3. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU
Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
[TBL] [Abstract][Full Text] [Related]
4. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Mc Manus J; Mc Eneny J; Thompson W; Young IS
Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
[TBL] [Abstract][Full Text] [Related]
5. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
Schram JH; Boerrigter PJ; The TY
Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
[TBL] [Abstract][Full Text] [Related]
6. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Sendag F; Karadadas N; Ozsener S; Bilgin O
Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
[TBL] [Abstract][Full Text] [Related]
7. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
[TBL] [Abstract][Full Text] [Related]
8. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
[TBL] [Abstract][Full Text] [Related]
9. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
[TBL] [Abstract][Full Text] [Related]
10. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
[TBL] [Abstract][Full Text] [Related]
11. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
13. The effects of 17 beta-oestradiol plus dydrogesterone compared with conjugated equine oestrogens plus medroxyprogesterone acetate on lipids, apolipoproteins and lipoprotein(a).
de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ
Maturitas; 2004 Nov; 49(3):253-63. PubMed ID: 15488354
[TBL] [Abstract][Full Text] [Related]
14. Effects of oophorectomy and hormone replacement therapy on plasma lipids.
Castelo-Branco C; Casals E; Sanllehy C; González-Merlo J; Iglesias X
Maturitas; 1993 Sep; 17(2):113-22. PubMed ID: 8231903
[TBL] [Abstract][Full Text] [Related]
15. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration.
Dick IM; Prince RL; Kelly JJ; Ho KK
Clin Endocrinol (Oxf); 1995 Aug; 43(2):219-24. PubMed ID: 7554318
[TBL] [Abstract][Full Text] [Related]
17. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
Cromie MA; Maile MH; Wajszczuk CP
Contraception; 2000 Jan; 61(1):51-9. PubMed ID: 10745070
[TBL] [Abstract][Full Text] [Related]
19. Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.
Cortellaro M; Nencioni T; Boschetti C; Ortolani S; Buzzi F; Francucci B; Caraceni MP; Abelli P; Polvani F; Zanussi C
Eur J Clin Pharmacol; 1991; 41(6):555-9. PubMed ID: 1667755
[TBL] [Abstract][Full Text] [Related]
20. Effects of postmenopausal hormone therapy every day and every other day on lipid levels according to difference in body mass index.
Yasui T; Umino Y; Takikawa M; Uemura H; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Menopause; 2005 Mar; 12(2):223-31. PubMed ID: 15772571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
